News
LEUKEMIA 360: A Unique Event to Accelerate Research on Leukemia and Related Diseases on November 13 in Paris
Nov. 4, 2024, 10:15 a.m.
Paris, October 30, 2024 – The countdown has begun! In less than two weeks, the inaugural edition of LEUKEMIA 360 will open in Paris, bringing together over 200 experts in leukemia and related diseases.
> Read moreLEUKEMIA 360 : un événement unique pour accélérer la recherche contre les leucémies et maladies apparentées le 13 novembre à Paris
Nov. 1, 2024, 12:21 p.m.
LEUKEMIA 360 ouvrira ses portes à Paris pour la première édition d’une rencontre inédite rassemblant plus de 200 experts des leucémies et maladies apparentées.
> Read moreUn partenariat inédit, lancé durant Septembre Rouge !
Sept. 30, 2024, 6:23 p.m.
Les instituts Carnot OPALE et CALYM et le Paris-Saclay Cancer Cluster s’associent pour accélérer la recherche en oncohématologie et soutenir l'innovation thérapeutique.
> Read moreLancement de l’appel à candidatures pour le programme OncoEntrepreneur 2024
Sept. 26, 2024, 12:15 p.m.
L’Institut Carnot OPALE et le PSCC ouvrent les candidatures pour le programme OncoEntrepreneur, dédié aux projets Healthtech en oncologie. Formation, accompagnement et networking au programme !
> Read moreWe are participating at OncoSTART alongside two spin-offs !
Sept. 24, 2024, 10:12 a.m.
First day of the OncoSTART Entrepreneurship School at Paris Saclay Cancer Cluster (PSCC) premises !
> Read morePublic-Private Partnerships in the field of Leukemia and Related Diseases
July 25, 2024, 12:27 p.m.
Driving innovation through public-private partnerships
> Read moreTransforming leukemia treatment: Inside CAR-T cell therapy
July 23, 2024, 8:17 p.m.
CAR-T cell therapy represents a significant leap forward in leukemia treatment.
> Read moreLEUKEMIA 360 : Meet the leukemia experts in Paris
July 23, 2024, 4:57 p.m.
Organized by Opale, we expect the 2024 edition of LEUKEMIA 360 to foster value-added R&D partnerships between industry and academia and accelerate innovation in the field of leukemia and related diseases.
> Read moreBreaking new ground in Leukemia R&D !
July 9, 2024, 6:58 p.m.
We are proud to announce a strategic partnership with the renowned Shanghai Institute of Hematology (SIH) at Ruijin Hospital, China.
> Read moreUNITC labellisé par l'INCA
April 16, 2024, 1:21 p.m.
Le consortium dédié aux CAR-T cells UNITC a été labellisé par l'INCa
> Read more